Association of diabetes and cancer mortality in American Indians: the Strong Heart Study

Cancer Causes and Control

Volumn 26, Issue 11, 2015, Pages 1551-1560

  Best, Lyle G ^a,k   García Esquinas, Esther ^b,c,d   Yeh, Jeun Liang ^e   Yeh, Fawn ^e   Zhang, Ying ^e   Lee, Elisa T ^e   Howard, Barbara V ^f,g   Farley, John H ^h   Welty, Thomas K ^a   Rhoades, Dorothy A ⁱ   Rhoades, Everett R ^e   Umans, Jason G ^f   Navas Acien, Ana ^b,j  

^a MISSOURI BREAKS INDUSTRIES RESEARCH INC   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f MEDSTAR RESEARCH INSTITUTE   (United States)

^g Delaware   (United States)

^h CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NONE   (United States)

more..

Author keywords

American Indian; Cancer; Diabetes mellitus

Indexed keywords

ARSENIC; HEMOGLOBIN A1C;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CAUSE OF DEATH; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; POPULATION EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; STOMACH CANCER; BODY MASS; DIABETES MELLITUS; INCIDENCE; MORTALITY; NEOPLASMS; OBESITY; SMOKING; STATISTICS AND NUMERICAL DATA;

AGED; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; SMOKING;

EID: 84943359138     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0648-7     Document Type: Article

References (55)

1. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA (2011) Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 106:1911–1921
2. Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K et al (2012) Diabetes and breast cancer risk: a meta-analysis. Br J Cancer 107:1608–1617
3. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685
4. Rosato V, Tavani A, Bosetti C, Pelucchi C, Talamini R, Polesel J et al (2011) Metabolic syndrome and pancreatic cancer risk: a case–control study in Italy and meta-analysis. Metabolism 60:1372–1378
5. Faulds MH, Dahlman-Wright K (2012) Metabolic diseases and cancer risk. Curr Opin Oncol 24:58–61
6. Noto H, Tsujimoto T, Sasazuki T, Noda M (2011) Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract 17:616–628
7. Dang CV (2012) Links between metabolism and cancer. Genes Dev 26:877–890
8. Santra A, Kumar R, Sharma P, Bal C, Kumar A, Julka PK et al (2012) F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI. Eur J Radiol 81:508–513
9. Barros LF, San Martín A, Sotelo-Hitschfeld T, Lerchundi R, Fernández-Moncada I, Ruminot I et al (2013) Small is fast: astrocytic glucose and lactate metabolism at cellular resolution. Front Cell Neurosci 7:27
10. Chen W, Wang S, Tian T, Bai J, Hu Z, Xu Y et al (2009) Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. Eur J Hum Genet 17:1668–1675
11. Chen J (2011) Multiple signal pathways in obesity-associated cancer. Obes Rev 12:1063–1070
12. White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS (2014) Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health 104(Suppl 3):S377–S387
13. US Department of Health and Human Services (2012) Health, United States, 2011: with special feature on socioeconomic status and health. National Center for Health Statistics, Hyattsville
14. Lee ET, Howard BV, Savage PJ, Cowan LD, Fabsitz RR, Oopik AJ et al (1995) Diabetes and impaired glucose tolerance in three American Indian populations aged 45–74 years. The Strong Heart Study. Diabetes Care 18:599–610
15. Centers for Disease Control and Prevention (CDC) (2003) Diabetes prevalence among American Indians and Alaska Natives and the overall population—United States, 1994–2002. MMWR Morb Mortal Wkly Rep 52:702–704
16. Valway S, Freeman W, Kaufman S, Welty T, Helgerson SD, Gohdes D (1993) Prevalence of diagnosed diabetes among American Indians and Alaska Natives, 1987. Estimates from a national outpatient data base. Diabetes Care 1993(16):271–276
17. Lu W, Resnick HE, Jain AK, Adams-Campbell LL, Jablonski KA, Gottlieb AM et al (2003) Effects of isolated post-challenge hyperglycemia on mortality in American Indians: the Strong Heart Study. Ann Epidemiol 13:182–188
18. Zhang Y, Lee ET, Howard BV, Best LG, Umans JG, Yeh J et al (2013) Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study. Diabetes Care 36:3195–3200
19. De Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Calhoun D et al (2011) Cardiac geometry and function in diabetic or prediabetic adolescents and young adults: the Strong Heart Study. Diabetes Care 34:2300–2305
20. Lu WQ, Resnick HE, Jablonski KA, Jain AK, Jones KL, Robbins DC et al (2004) Effects of glycaemic control on cardiovascular disease in diabetic American Indians: the Strong Heart Study. Diabet Med 21:311–317
21. Devereux RB, Roman MJ, Paranicas M, Lee ET, Welty TK, Fabsitz RR et al (2001) A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. Am Heart J 141:439–446
22. Lu W, Jablonski KA, Resnick HE, Jain AK, Jones KL, Gottlieb AM et al (2003) Alcohol intake and glycemia in American Indians: the Strong Heart Study. Metabolism 52:129–135
23. García-Esquinas E, Pollán M, Umans JG, Francesconi KA, Goessler W, Guallar E et al (2013) Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study. Cancer Epidemiol Biomark Prev 22:1944–1953
24. Gribble MO, Howard BV, Umans JG, Shara NM, Francesconi KA, Goessler W et al (2012) Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am J Epidemiol 176:865–874
25. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
26. Tian T, Zhang LQ, Ma XH, Zhou JN, Shen J (2012) Diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis. Exp Clin Endocrinol Diabetes 120:217–223
27. Huang W, Ren H, Ben Q, Cai Q, Zhu W, Li Z (2012) Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies. Cancer Causes Control 23:263–272
28. Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y et al (2012) Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 130:1639–1648
29. Yang WS, Va P, Bray F, Gao S, Gao J, Li HL et al (2011) The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS ONE 6:e27326
30. Yoon JM, Son KY, Eom CS, Durrance D, Park SM (2013) Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis. World J Gastroenterol 19:936–945
31. Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V et al (2012) Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res 2012:789174
32. Steuerman R, Shevah O, Laron Z (2011) Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur J Endocrinol 164:485–489
33. Hemkens LG, Grouven U, Bender R, Günster C, Gutschmidt S, Selke GW et al (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52:1732–1744
34. Mannucci E (2012) Insulin therapy and cancer in type 2 diabetes. ISRN Endocrinol 2012:240634
35. Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766–1777
36. Franciosi M, Lucisano G, Lapice E, Strippoli GF, Pellegrini F, Nicolucci A (2013) Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PLoS ONE 8:e71583
37. Tsilidis KK, Capothanassi D, Allen NE, Rizos EC, Lopez DS, van Veldhoven K et al (2014) Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial. Diabetes Care 37:2522–2532
38. Capasso I, Esposito E, Pentimalli F, Montella M, Crispo A, Maurea N et al (2013) Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: national cancer institute of Naples experience. J Exp Clin Cancer Res. 32:14
39. Khattab MA, Eslam M, Mousa YI, Ela-adawy N, Fathy S, Shatat M et al (2012) Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma. Ann Hepatol 11:487–494
40. Sieri S, Muti P, Claudia A, Berrino F, Pala V, Grioni S et al (2012) Prospective study on the role of glucose metabolism in breast cancer occurrence. Int J Cancer 130:921–929
41. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350:g7607
42. Choufani S, Shuman C, Weksberg R (2010) Beckwith–Wiedemann syndrome. Am J Med Genet C Semin Med Genet 154C:343–354
43. Tseng CH, Tseng FH (2014) Diabetes and gastric cancer: the potential links. World J Gastroenterol 20:1701–1711
44. Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA (2012) Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control 23:967–981
45. Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev 15:2056–2062
46. Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124:1398–1403
47. Carstensen B, Witte DR, Friis S (2012) Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia 55:948–958
48. Cai H, Xu Z, Xu T, Yu B, Zou Q (2015) Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies. Diabetes Metab Res Rev 31:336–343
49. Collaboration Emerging Risk Factors, Seshasai SR, Kaptoge S, Thompson A, DiAngelantonio E, Gao P, Sarwar N et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841
50. Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, Gaziano JM et al (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9:1039–1047
51. Hammarsten J, Högstedt B (2005) Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41:2887–2895
52. Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA (2006) Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55:1074–1079
53. Gerich JE (2003) Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78:447–456
54. Sittadjody S, Ilangovan R, Thangasamy T, Vignesh RC, Veni S, Bertoni AG et al (2012) Age-related changes in serum levels of insulin-like growth factor-II and its binding proteins correlate with calcaneal bone mineral density among post-menopausal South-Indian women. Clin Chim Acta 414:281–288
55. Navas-Acien A, Umans JG, Howard BV, Goessler W, Francesconi KA, Crainiceanu CM et al (2009) Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study. Environ Health Perspect 117:1428–1433